The impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in Norway

Abstract Background Posttraumatic stress disorder (PTSD) is associated with cardiometabolic diseases, concurrent anxiety, alcohol use disorder and depression. The relationship between PTSD and cardiometabolic diseases are still unclear, and less is known about the effects of socioeconomic status, co...

Full description

Bibliographic Details
Main Authors: Grethe Emilie Roer, Lars Lien, Ingeborg Bolstad, Jan O. Aaseth, Dawit Shawel Abebe
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Psychiatry
Subjects:
Online Access:https://doi.org/10.1186/s12888-023-04866-x
_version_ 1797822749563944960
author Grethe Emilie Roer
Lars Lien
Ingeborg Bolstad
Jan O. Aaseth
Dawit Shawel Abebe
author_facet Grethe Emilie Roer
Lars Lien
Ingeborg Bolstad
Jan O. Aaseth
Dawit Shawel Abebe
author_sort Grethe Emilie Roer
collection DOAJ
description Abstract Background Posttraumatic stress disorder (PTSD) is associated with cardiometabolic diseases, concurrent anxiety, alcohol use disorder and depression. The relationship between PTSD and cardiometabolic diseases are still unclear, and less is known about the effects of socioeconomic status, comorbid anxiety, comorbid alcohol use disorder and comorbid depression. The study, therefore, aims to examine the risk of developing cardiometabolic diseases including type 2 diabetes mellitus over time in PTSD patients, and to what extent socioeconomic status, comorbid anxiety, comorbid alcohol use disorder and comorbid depression attenuate associations between PTSD and risk of developing cardiometabolic diseases. Method A retrospective, register-based cohort study with 6-years follow-up of adult (> 18 years) PTSD patients (N = 7 852) compared with the general population (N = 4 041 366), was performed. Data were acquired from the Norwegian Patient Registry and Statistic Norway. Cox proportional regression models were applied to estimate hazard ratios (HRs) (99% confidence intervals) of cardiometabolic diseases among PTSD patients. Results Significantly (p < 0.001) higher age and gender adjusted HRs were disclosed for all cardiometabolic diseases among PTSD patients compared to the population without PTSD, with a variation in HR from 3.5 (99% CI 3.1–3.9) for hypertensive diseases to HR = 6.5 (5.7–7.5) for obesity. When adjusted for socioeconomic status and comorbid mental disorders, reductions were observed, especially for comorbid depression, for which the adjustment resulted in HR reduction of about 48.6% for hypertensive diseases and 67.7% for obesity. Conclusions PTSD was associated with increased risk of developing cardiometabolic diseases, though attenuated by socioeconomic status and comorbid mental disorders. Health care professionals should be attentive towards the burden and increased risk that low socioeconomic status and comorbid mental disorders may represent for PTSD patients’ cardiometabolic health.
first_indexed 2024-03-13T10:13:46Z
format Article
id doaj.art-97a610248237401b878ebedf20ec54ad
institution Directory Open Access Journal
issn 1471-244X
language English
last_indexed 2024-03-13T10:13:46Z
publishDate 2023-05-01
publisher BMC
record_format Article
series BMC Psychiatry
spelling doaj.art-97a610248237401b878ebedf20ec54ad2023-05-21T11:22:48ZengBMCBMC Psychiatry1471-244X2023-05-012311910.1186/s12888-023-04866-xThe impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in NorwayGrethe Emilie Roer0Lars Lien1Ingeborg Bolstad2Jan O. Aaseth3Dawit Shawel Abebe4Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital TrustNorwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital TrustFaculty of Social and Health Sciences, Inland Norway University of Applied SciencesFaculty of Social and Health Sciences, Inland Norway University of Applied SciencesNorwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital TrustAbstract Background Posttraumatic stress disorder (PTSD) is associated with cardiometabolic diseases, concurrent anxiety, alcohol use disorder and depression. The relationship between PTSD and cardiometabolic diseases are still unclear, and less is known about the effects of socioeconomic status, comorbid anxiety, comorbid alcohol use disorder and comorbid depression. The study, therefore, aims to examine the risk of developing cardiometabolic diseases including type 2 diabetes mellitus over time in PTSD patients, and to what extent socioeconomic status, comorbid anxiety, comorbid alcohol use disorder and comorbid depression attenuate associations between PTSD and risk of developing cardiometabolic diseases. Method A retrospective, register-based cohort study with 6-years follow-up of adult (> 18 years) PTSD patients (N = 7 852) compared with the general population (N = 4 041 366), was performed. Data were acquired from the Norwegian Patient Registry and Statistic Norway. Cox proportional regression models were applied to estimate hazard ratios (HRs) (99% confidence intervals) of cardiometabolic diseases among PTSD patients. Results Significantly (p < 0.001) higher age and gender adjusted HRs were disclosed for all cardiometabolic diseases among PTSD patients compared to the population without PTSD, with a variation in HR from 3.5 (99% CI 3.1–3.9) for hypertensive diseases to HR = 6.5 (5.7–7.5) for obesity. When adjusted for socioeconomic status and comorbid mental disorders, reductions were observed, especially for comorbid depression, for which the adjustment resulted in HR reduction of about 48.6% for hypertensive diseases and 67.7% for obesity. Conclusions PTSD was associated with increased risk of developing cardiometabolic diseases, though attenuated by socioeconomic status and comorbid mental disorders. Health care professionals should be attentive towards the burden and increased risk that low socioeconomic status and comorbid mental disorders may represent for PTSD patients’ cardiometabolic health.https://doi.org/10.1186/s12888-023-04866-xPosttraumatic stress disorderAlcohol use disorderDepressionComorbidityCardiovascular diseasesMetabolic diseases
spellingShingle Grethe Emilie Roer
Lars Lien
Ingeborg Bolstad
Jan O. Aaseth
Dawit Shawel Abebe
The impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in Norway
BMC Psychiatry
Posttraumatic stress disorder
Alcohol use disorder
Depression
Comorbidity
Cardiovascular diseases
Metabolic diseases
title The impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in Norway
title_full The impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in Norway
title_fullStr The impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in Norway
title_full_unstemmed The impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in Norway
title_short The impact of PTSD on risk of cardiometabolic diseases: a national patient cohort study in Norway
title_sort impact of ptsd on risk of cardiometabolic diseases a national patient cohort study in norway
topic Posttraumatic stress disorder
Alcohol use disorder
Depression
Comorbidity
Cardiovascular diseases
Metabolic diseases
url https://doi.org/10.1186/s12888-023-04866-x
work_keys_str_mv AT gretheemilieroer theimpactofptsdonriskofcardiometabolicdiseasesanationalpatientcohortstudyinnorway
AT larslien theimpactofptsdonriskofcardiometabolicdiseasesanationalpatientcohortstudyinnorway
AT ingeborgbolstad theimpactofptsdonriskofcardiometabolicdiseasesanationalpatientcohortstudyinnorway
AT janoaaseth theimpactofptsdonriskofcardiometabolicdiseasesanationalpatientcohortstudyinnorway
AT dawitshawelabebe theimpactofptsdonriskofcardiometabolicdiseasesanationalpatientcohortstudyinnorway
AT gretheemilieroer impactofptsdonriskofcardiometabolicdiseasesanationalpatientcohortstudyinnorway
AT larslien impactofptsdonriskofcardiometabolicdiseasesanationalpatientcohortstudyinnorway
AT ingeborgbolstad impactofptsdonriskofcardiometabolicdiseasesanationalpatientcohortstudyinnorway
AT janoaaseth impactofptsdonriskofcardiometabolicdiseasesanationalpatientcohortstudyinnorway
AT dawitshawelabebe impactofptsdonriskofcardiometabolicdiseasesanationalpatientcohortstudyinnorway